The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health
This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approac...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Flynn, Michelle [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2019transfer abstract |
|---|
| Systematik: |
|
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Error-free DNA-damage tolerance in - Xu, Xin ELSEVIER, 2015, Orlando, Fla |
|---|---|
| Übergeordnetes Werk: |
volume:62 ; year:2019 ; number:1 ; pages:21-28 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.pcad.2018.12.005 |
|---|
| Katalog-ID: |
ELV045791368 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV045791368 | ||
| 003 | DE-627 | ||
| 005 | 20230626012313.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 191021s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.pcad.2018.12.005 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000521.pica |
| 035 | |a (DE-627)ELV045791368 | ||
| 035 | |a (ELSEVIER)S0033-0620(18)30252-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 050 |q VZ |
| 082 | 0 | 4 | |a 570 |q VZ |
| 084 | |a 12 |2 ssgn | ||
| 084 | |a BIODIV |q DE-30 |2 fid | ||
| 084 | |a WA 15000 |q VZ |2 rvk |0 (DE-625)rvk/147842: | ||
| 084 | |a 44.48 |2 bkl | ||
| 100 | 1 | |a Flynn, Michelle |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health |
| 264 | 1 | |c 2019transfer abstract | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. | ||
| 520 | |a This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. | ||
| 700 | 1 | |a Moran, Chelsea |4 oth | |
| 700 | 1 | |a Rash, Joshua A. |4 oth | |
| 700 | 1 | |a Campbell, Tavis S. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Xu, Xin ELSEVIER |t Error-free DNA-damage tolerance in |d 2015 |g Orlando, Fla |w (DE-627)ELV005094119 |
| 773 | 1 | 8 | |g volume:62 |g year:2019 |g number:1 |g pages:21-28 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.pcad.2018.12.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a FID-BIODIV | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | r | v | |a WA 15000 |b Zeitschriften |k Biologie |k Referateorgane und Zeitschriften |k Zeitschriften |0 (DE-625)rvk/147842: |0 (DE-576)206662238 |
| 936 | b | k | |a 44.48 |j Medizinische Genetik |q VZ |
| 951 | |a AR | ||
| 952 | |d 62 |j 2019 |e 1 |h 21-28 |g 8 | ||
| author_variant |
m f mf |
|---|---|
| matchkey_str |
flynnmichellemoranchelsearashjoshuaacamp:2019----:hcnrbtoopyhscaitretosorcsom |
| hierarchy_sort_str |
2019transfer abstract |
| bklnumber |
44.48 |
| publishDate |
2019 |
| allfields |
10.1016/j.pcad.2018.12.005 doi GBV00000000000521.pica (DE-627)ELV045791368 (ELSEVIER)S0033-0620(18)30252-4 DE-627 ger DE-627 rakwb eng 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Flynn, Michelle verfasserin aut The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. Moran, Chelsea oth Rash, Joshua A. oth Campbell, Tavis S. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:62 year:2019 number:1 pages:21-28 extent:8 https://doi.org/10.1016/j.pcad.2018.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 62 2019 1 21-28 8 |
| spelling |
10.1016/j.pcad.2018.12.005 doi GBV00000000000521.pica (DE-627)ELV045791368 (ELSEVIER)S0033-0620(18)30252-4 DE-627 ger DE-627 rakwb eng 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Flynn, Michelle verfasserin aut The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. Moran, Chelsea oth Rash, Joshua A. oth Campbell, Tavis S. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:62 year:2019 number:1 pages:21-28 extent:8 https://doi.org/10.1016/j.pcad.2018.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 62 2019 1 21-28 8 |
| allfields_unstemmed |
10.1016/j.pcad.2018.12.005 doi GBV00000000000521.pica (DE-627)ELV045791368 (ELSEVIER)S0033-0620(18)30252-4 DE-627 ger DE-627 rakwb eng 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Flynn, Michelle verfasserin aut The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. Moran, Chelsea oth Rash, Joshua A. oth Campbell, Tavis S. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:62 year:2019 number:1 pages:21-28 extent:8 https://doi.org/10.1016/j.pcad.2018.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 62 2019 1 21-28 8 |
| allfieldsGer |
10.1016/j.pcad.2018.12.005 doi GBV00000000000521.pica (DE-627)ELV045791368 (ELSEVIER)S0033-0620(18)30252-4 DE-627 ger DE-627 rakwb eng 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Flynn, Michelle verfasserin aut The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. Moran, Chelsea oth Rash, Joshua A. oth Campbell, Tavis S. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:62 year:2019 number:1 pages:21-28 extent:8 https://doi.org/10.1016/j.pcad.2018.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 62 2019 1 21-28 8 |
| allfieldsSound |
10.1016/j.pcad.2018.12.005 doi GBV00000000000521.pica (DE-627)ELV045791368 (ELSEVIER)S0033-0620(18)30252-4 DE-627 ger DE-627 rakwb eng 050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842: 44.48 bkl Flynn, Michelle verfasserin aut The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health 2019transfer abstract 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. Moran, Chelsea oth Rash, Joshua A. oth Campbell, Tavis S. oth Enthalten in Elsevier Xu, Xin ELSEVIER Error-free DNA-damage tolerance in 2015 Orlando, Fla (DE-627)ELV005094119 volume:62 year:2019 number:1 pages:21-28 extent:8 https://doi.org/10.1016/j.pcad.2018.12.005 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA WA 15000 Zeitschriften Biologie Referateorgane und Zeitschriften Zeitschriften (DE-625)rvk/147842: (DE-576)206662238 44.48 Medizinische Genetik VZ AR 62 2019 1 21-28 8 |
| language |
English |
| source |
Enthalten in Error-free DNA-damage tolerance in Orlando, Fla volume:62 year:2019 number:1 pages:21-28 extent:8 |
| sourceStr |
Enthalten in Error-free DNA-damage tolerance in Orlando, Fla volume:62 year:2019 number:1 pages:21-28 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Medizinische Genetik |
| institution |
findex.gbv.de |
| dewey-raw |
050 |
| isfreeaccess_bool |
false |
| container_title |
Error-free DNA-damage tolerance in |
| authorswithroles_txt_mv |
Flynn, Michelle @@aut@@ Moran, Chelsea @@oth@@ Rash, Joshua A. @@oth@@ Campbell, Tavis S. @@oth@@ |
| publishDateDaySort_date |
2019-01-01T00:00:00Z |
| hierarchy_top_id |
ELV005094119 |
| dewey-sort |
250 |
| id |
ELV045791368 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045791368</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626012313.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pcad.2018.12.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000521.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045791368</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0033-0620(18)30252-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">050</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">12</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WA 15000</subfield><subfield code="q">VZ</subfield><subfield code="2">rvk</subfield><subfield code="0">(DE-625)rvk/147842:</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.48</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Flynn, Michelle</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moran, Chelsea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rash, Joshua A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Campbell, Tavis S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Xu, Xin ELSEVIER</subfield><subfield code="t">Error-free DNA-damage tolerance in</subfield><subfield code="d">2015</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV005094119</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:62</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:21-28</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pcad.2018.12.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="r" ind2="v"><subfield code="a">WA 15000</subfield><subfield code="b">Zeitschriften</subfield><subfield code="k">Biologie</subfield><subfield code="k">Referateorgane und Zeitschriften</subfield><subfield code="k">Zeitschriften</subfield><subfield code="0">(DE-625)rvk/147842:</subfield><subfield code="0">(DE-576)206662238</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.48</subfield><subfield code="j">Medizinische Genetik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">62</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="h">21-28</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| author |
Flynn, Michelle |
| spellingShingle |
Flynn, Michelle ddc 050 ddc 570 ssgn 12 fid BIODIV rvk WA 15000 bkl 44.48 The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health |
| authorStr |
Flynn, Michelle |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV005094119 |
| format |
electronic Article |
| dewey-ones |
050 - General serial publications 570 - Life sciences; biology |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842 44.48 bkl The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health |
| topic |
ddc 050 ddc 570 ssgn 12 fid BIODIV rvk WA 15000 bkl 44.48 |
| topic_unstemmed |
ddc 050 ddc 570 ssgn 12 fid BIODIV rvk WA 15000 bkl 44.48 |
| topic_browse |
ddc 050 ddc 570 ssgn 12 fid BIODIV rvk WA 15000 bkl 44.48 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
c m cm j a r ja jar t s c ts tsc |
| hierarchy_parent_title |
Error-free DNA-damage tolerance in |
| hierarchy_parent_id |
ELV005094119 |
| dewey-tens |
050 - Magazines, journals & serials 570 - Life sciences; biology |
| hierarchy_top_title |
Error-free DNA-damage tolerance in |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV005094119 |
| title |
The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health |
| ctrlnum |
(DE-627)ELV045791368 (ELSEVIER)S0033-0620(18)30252-4 |
| title_full |
The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health |
| author_sort |
Flynn, Michelle |
| journal |
Error-free DNA-damage tolerance in |
| journalStr |
Error-free DNA-damage tolerance in |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
000 - Computer science, information & general works 500 - Science |
| recordtype |
marc |
| publishDateSort |
2019 |
| contenttype_str_mv |
zzz |
| container_start_page |
21 |
| author_browse |
Flynn, Michelle |
| container_volume |
62 |
| physical |
8 |
| class |
050 VZ 570 VZ 12 ssgn BIODIV DE-30 fid WA 15000 VZ rvk (DE-625)rvk/147842 44.48 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Flynn, Michelle |
| doi_str_mv |
10.1016/j.pcad.2018.12.005 |
| normlink |
RVK/147842: 206662238 |
| normlink_prefix_str_mv |
(DE-625)rvk/147842: (DE-576)206662238 |
| dewey-full |
050 570 |
| title_sort |
contribution of psychosocial interventions to precision medicine for heart health |
| title_auth |
The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health |
| abstract |
This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. |
| abstractGer |
This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. |
| abstract_unstemmed |
This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U FID-BIODIV SSG-OLC-PHA |
| container_issue |
1 |
| title_short |
The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health |
| url |
https://doi.org/10.1016/j.pcad.2018.12.005 |
| remote_bool |
true |
| author2 |
Moran, Chelsea Rash, Joshua A. Campbell, Tavis S. |
| author2Str |
Moran, Chelsea Rash, Joshua A. Campbell, Tavis S. |
| ppnlink |
ELV005094119 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth |
| doi_str |
10.1016/j.pcad.2018.12.005 |
| up_date |
2024-07-06T18:30:01.842Z |
| _version_ |
1803855438119174144 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV045791368</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230626012313.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">191021s2019 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.pcad.2018.12.005</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000521.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV045791368</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0033-0620(18)30252-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">050</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">12</subfield><subfield code="2">ssgn</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">BIODIV</subfield><subfield code="q">DE-30</subfield><subfield code="2">fid</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WA 15000</subfield><subfield code="q">VZ</subfield><subfield code="2">rvk</subfield><subfield code="0">(DE-625)rvk/147842:</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.48</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Flynn, Michelle</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="4"><subfield code="a">The Contribution of Psychosocial Interventions to Precision Medicine for Heart Health</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2019transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This paper reviews the value of incorporating psychosocial interventions into precision medicine for heart health. First, we review the empirical literature on prevalence of common mental health comorbidities among individuals with cardiovascular disease (CVD). We then review transdiagnostic approaches for conceptualization and treatment of mental health in individuals with CVD. We highlight recent studies that have used novel methods to individualize psychosocial interventions. Finally, we propose a preliminary framework intended to support Health Care Providers in individualizing treatment, which includes: 1) assessment of patient risk factors, characteristics, and expectations; 2) consideration of transdiagnostic processes underlying several psychiatric symptoms that contribute to CVD risk; 3) patient engagement in shared decision-making for psychosocial treatment; and 4) ongoing outcome monitoring to evaluate treatment responsiveness. We anticipate that the proposed framework will evolve with the emergence of new empirical evidence; as such, future directions and challenges for research are discussed.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moran, Chelsea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rash, Joshua A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Campbell, Tavis S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Xu, Xin ELSEVIER</subfield><subfield code="t">Error-free DNA-damage tolerance in</subfield><subfield code="d">2015</subfield><subfield code="g">Orlando, Fla</subfield><subfield code="w">(DE-627)ELV005094119</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:62</subfield><subfield code="g">year:2019</subfield><subfield code="g">number:1</subfield><subfield code="g">pages:21-28</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.pcad.2018.12.005</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">FID-BIODIV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="r" ind2="v"><subfield code="a">WA 15000</subfield><subfield code="b">Zeitschriften</subfield><subfield code="k">Biologie</subfield><subfield code="k">Referateorgane und Zeitschriften</subfield><subfield code="k">Zeitschriften</subfield><subfield code="0">(DE-625)rvk/147842:</subfield><subfield code="0">(DE-576)206662238</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.48</subfield><subfield code="j">Medizinische Genetik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">62</subfield><subfield code="j">2019</subfield><subfield code="e">1</subfield><subfield code="h">21-28</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
| score |
7.401717 |